A few days ago, I appeared as a panellist on a webinar discussing the results of a recent survey on patient awareness of clinical trials within the hepatitis C patient community, hosted by Tudor-Reilly. We discussed how to raise awareness of HepC clinical trials, some of the issues around conducting studies in this therapeutic area, and how these findings might be applied to patient engagement in clinical research more generally.
The webinar was led by Peter Coe, Chairman of Tudor-Reilly, and the other panellists were:
- Dr Matthew Foxton, consultant hepatologist
- Andrew Langford, CEO of the British Liver Trust
- Karen Donovan, principal of healthcare consultants Health Business Group
The audio and slides from the webinar are now available [here].